Evidence map›Paper›PMID 34851156›Full record

ArticleMicrobiology spectrum2021

Sporadic Dissemination of

Ying-Ying Cheng, Yang Liu, Yong Chen, Fu-Man Huang, Rong-Chang Chen, Yong-Hong Xiao, Kai Zhou

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Antibiotic Resistance ofAnimals : an open access journal from MDPI · 2026
    Article
  3. Article
  4. Article
  5. Transfer and Fitness of ISMicroorganisms · 2025
    Article
  6. Exploring the Multifaceted GenusJournal of microbiology and biotechnology · 2025
    Review
  7. Article
  8. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
  9. OvercomingFrontiers in microbiology · 2024
    Article
  10. Article
  11. Article
  12. Characteristics ofAntibiotics (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Occurrence and Characterization of NDM-1-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ying-Ying Cheng *Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Guangzhou, China.ORCID 0000-0002-7698-8233
Yang Liu *Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Guangzhou, China.
Yong ChenShenzhen Institute of Respiratory Diseases, Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Guangzhou, China.
Fu-Man HuangCollege of Biotechnology, Guilin Medical Universitygrid.443385.d, Guilin, China.
Rong-Chang ChenShenzhen Institute of Respiratory Diseases, Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Guangzhou, China.
Yong-Hong XiaoCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.ORCID 0000-0003-4845-5904
Kai ZhouShenzhen Institute of Respiratory Diseases, Second Clinical Medical College (Shenzhen People's Hospital), Jinan University, Guangzhou, China.ORCID 0000-0002-7320-291X
Jinan University · CNBGI Group (China) · CNGuilin Medical University · CNState Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of high-level tigecycline resistance mediated by plasmid-borne

Indexed as

AcinetobacterAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsBacterial ProteinsCattleLivestockMicrobial Sensitivity TestsMixed Function OxygenasesPlasmidsSheepSwineTetracycline ResistanceTigecyclineAnti-Bacterial AgentsBacterial ProteinsMixed Function OxygenasesTigecyclineAcinetobacterplasmid-borne tigecycline resistanceself-transmissible plasmidtet(X3)tet(X6)

Identifiers

PMID34851156
PMCPMC8635130
OpenAlexW3215702307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.